Loading
Everything in development, the open problems and what is being done about them, the roadmaps, and what changed on this record.
What is in development for Papillary thyroid cancer, drawn from the whole corpus: 0 items. Drugs are grouped by the most advanced trial phase they have reached anywhere; approved treatments sit under standard of care. Technologies are the methods being tested for this cancer, trials are the studies recorded here, and ideas are proposals not yet in a trial.
Nothing recorded in development for this cancer yet.
Overdiagnosis and overtreatment of small tumours found by imaging.
Which intermediate-risk patients truly benefit from radioactive iodine.
Resistance to kinase inhibitors in refractory disease.
Dated changes read from the records linked to this cancer: approvals, regulatory steps, reported trials, guideline versions and milestones. Newest first; no date is inferred.
On EdgeAll 7 changes by month →When this page itself was last checked or edited.
Both trials found equivalent outcomes without ablation.
A milestone in how this cancer is treated.
A milestone in how this cancer is treated.
Ito and Miyauchi's series of over a thousand patients.
A milestone in how this cancer is treated.